Table 4.

Adjusted analysis for the association between cardiac injury and in-hospital mortality, and between acute cardiac injury and the composite of invasive ventilation support in patients hospitalized with COVID-19.

	Mortality		Composite outcomes of invasive ventilation support
	Hazard Ratio (HR) (95% CI)	P-value	HR (95% CI)	P-Value
Age	1.009 (1.025-0.993)	0.276	1.007 (1.025-0990)	0.422
Oxygen parameters	0.989 (0.999-0.979)	0.040*	0.988 (0.998-0.977)	0.019*
Systolic blood pressure	0.994 (1.001-0.987)	0.076	0.994 (1.002-0.986)	0.132
Acute cardiac injury	1.620 (2.562-1.024)	0.039*	1.668 (2.692-1.033)	0036*
Fibrinogen	1.028 (1.142-0925)	0611	1.047 (1.174-0.933)	0435
Creatinin	1.007(1.017-0.997)	0.185	0.999 (1.011-0.986)	0829
Fast Blood Glucose	1.192 (1.501-0.946)	0.137	1.216 (1.546-0.957)	0.109
C-Reactiv Protein	1.002 (1.004-1.000)	0.036*	1.002 (1.004-0.999)	0146
Lactate Dehydrogenase	1.001 (1.001-1.000)	<0.001*	1.001 (1.001-1.000)	<0.001*
Lymphocyte cells	1 (1.000-1.000)	<0.001*	1.000 (1.000-1.000)	<0.001*
Procalcitonin	0.993 (1.003-0.983)	0.187	0.995 (1.006-0.984)	0.414
D-Dimers	1.005 (1.017-0.993)	0.419	1.004 (1.018-0.990)	0.568
Gender	1.312 (1.927-0.893)	0.167	1.498 (2.268-0.990)	0.056
Diabetes	1.095 (1.757-0.683)	0.706	0981 (1611-0597)	0.939
Hypertension	0.691 (1.059-0.452)	0090	0670 (1051-0427)	0.081
Previous history of Coronary Artery Disease	0.674 (1.305-0.348)	0.242	0.655 (1.307-0.328)	0.230